Interstitial cystitis/ bladder pain syndrome (IC/BPS) is a chronic inflammation that results in recurring pain in the bladder and the surrounding pelvic region caused by abnormal excitability of micturition reflexes. Spinal cord stimulation (SCS) is currently in clinical use for the attenuation of neuropathic pain, and has been identified for amelioration of pain in a rodent model of colorectal distention. This study aimed to investigate the potential effect of SCS on attenuation of visceral pain-related visceromotor reflexes (VMR) in rodents with cyclophosphamide-induced cystitis.
INTRODUCTION AND OBJECTIVES:
Interstitial cystitis/ bladder pain syndrome (IC/BPS) is a chronic inflammation that results in recurring pain in the bladder and the surrounding pelvic region caused by abnormal excitability of micturition reflexes. Spinal cord stimulation (SCS) is currently in clinical use for the attenuation of neuropathic pain, and has been identified for amelioration of pain in a rodent model of colorectal distention. This study aimed to investigate the potential effect of SCS on attenuation of visceral pain-related visceromotor reflexes (VMR) in rodents with cyclophosphamide-induced cystitis.
METHODS: Female Sprague-Dawley rats underwent intraperitoneal injection of cyclophosphamide (CYP, n¼8) or saline (controls, n¼4). 48 hours after CYP or saline injections, all rats underwent surgical preparations under urethane anesthesia. Stimulation wires were placed on the dorsal surface of the spinal segments of L2 and L3 for SCS. A PE-50 tubing was inserted into the bladder to obtain the intravesical pressure (IVP). Two wires are placed in the left external abdominal oblique muscle to record VMR. Before and after SCS (40 Hz, 0.2 ms for 25 min), VMR and maximum intravesical pressure (IVPmax) were obtained during continuous bladder infusion and isotonic bladder distention (IBD).
RESULTS: During continuous bladder infusion (Fig 1A) , the ratio of VMR threshold/IVPmax was significantly decreased in CYP rats indicating early VMR appearance compared to controls. SCS significantly increased the ratio indicating the delayed VMR appearance.
During IBD with urethral occlusion, SCS delayed the latency of VMR appearance in CYP rats below the voiding thresholds at 10 and 20 cmH2O. SCS also significantly decreased VMR area under the curve (AUC) in CYP rats (Figs 1B-C).
CONCLUSIONS: SCS attenuated visceral pain-related VMR in rats with CYP-induced cystitis suggesting a role for SCS in modulating visceral nociception and hyperalgesia. SCS appears to be a potential treatment of IC/PBS.
Source of Funding:
Supported by NIH (R01 DK106181) to HH Chang.
MP31-19
INTRODUCTION AND OBJECTIVES: While bladder hypersensitivity syndromes (BHS), such as overactive bladder (OAB) and interstitial cystitis/painful bladder syndrome (IC/PBS), classically exhibit the predominant symptoms of urgency and bladder pain, respectively, there is considerable symptom overlap between the conditions. Given this finding, we sought to define the fundamental features of each syndrome and refine diagnostic criteria through retrospective comparison of self-reported symptoms in female patients with a range of clinical presentations and symptom severities.
METHODS: We performed univariate analysis comparing responses to the Genitourinary Pain Index (GUPI), OAB Questionnaire (OABq) and O'Leary-Sant Indices (ICSI/ICPI) between 26 asymptomatic, 42 IC/PBS, and 27 OAB patients. Only five specific questions differed significantly between the IC/PBS and OAB groups, which assessed either urgency incontinence or bladder pain with filling. We used these questions to generate a novel composite scoring system with urgency incontinence (UI) and bladder pain (BP) domains to differentiate these populations.
RESULTS: While all validated questionnaires could distinguish between controls and BHS, no composite symptom scores differed significantly between the IC/PBS and OAB patients ( Figure 1A ). Only the GUPI Pain Domain was significantly different between OAB and IC/ PBS patients, but was not useful for diagnostic evaluation, resulting in a Positive Predictive Value (PPV) of only 56-60% for a range of cutoffs. Our composite score gave a PPV of 100% and Negative Predictive e406 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 Value (NPV) of 85% for a diagnosis of IC/PBS, as well as a PPV of 90% and NPV of 53% for a diagnosis of OAB ( Figure 1B) . These results are reflective of the prevalence of significant bladder pain (35%) in OAB patients and the presence of incontinence in IC/PBS patients. CONCLUSIONS: The significant overlap of urinary tract symptoms between OAB and IC/PBS suggests common pathological elements. Future studies aimed at assessing the diagnostic value of novel classification schemes that address symptoms rather than specific diagnoses may improve patient prognosis. Regardless, these data suggest a new paradigm for how we approach BHS.
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MP31-20 CORRELATION BETWEEN SYMPTOM SEVERITY AND BOTHER IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS
Jerry G Blaivas, New York, NY; Lucas J Policastro*, Brooklyn, NY; Zahava M Hirsch, New York, NY; Amy L O'Boyle, Bethesda, MD; David Chaikin, Morristown, NJ INTRODUCTION AND OBJECTIVES: In the absence of bother, most treatment algorithms for lower urinary tract symptoms (LUTS) recommend reassurance and follow-up. The assumptions behind this recommendation are that 1) if the symptoms are not bothersome, the underlying condition is not serious enough to warrant further investigation, and 2) the worse the symptoms, the greater a patient will be bothered by those symptoms. The aim of this study is to evaluate these hypotheses.
METHODS: This is an IRB approved retrospective multicenter study of consecutive men and women referred for LUTS who completed the LUTS symptom score (LUTSS) and/or AUA symptom score (AUASS) questionnaires. For those with more than one entry, the earliest score was used. Contemporaneous uroflow (Q), post-void residual (PVR), Patient Global Impression of Improvement (PGII), and clinical diagnosis were gathered when available. When more than one Q or PVR was available, the best one -greatest Q and lowest PVRwas used. Voided volumes <150 mL were excluded. Spearman correlations were calculated on the LUTSS bother score.
RESULTS: 1179 patients completed the LUTSS; correlations are seen in table 1. The overall correlation between total LUTSS and bother was moderate (plot 1). It was considerably lower among those who rated their improvement 00 worse 00 than 00 about the same 00 (r¼0.24 vs 0.67). Among specific symptom subscores, the correlation between the relevant subscore and bother was fairly low (r¼0.34-0.61). No correlation was found between Q or PVR versus bother or versus total LUTSS. CONCLUSIONS: The correlation between patient bother, symptom severity and the severity of the underlying LUT condition is inexact. Additionally, there is no correlation between Q, PVR and symptom severity. Some patients with little bother and few symptoms have serious underlying conditions; others are bothered severely by what appear to be minor symptoms.
